References
- Shively RM, Hoffman RS, Manini AF. Acute salicylate poisoning: risk factors for severe outcome. Clin Toxicol. 2017;55(3):175–180. doi: 10.1080/15563650.2016.1271127.
- Pearlman BL, Gambhir R. Salicylate intoxication: a clinical review. Postgrad Med. 2009;121(4):162–168. doi: 10.3810/pgm.2009.07.2041.
- Gummin DD, Mowry JB, Beuhler MC, et al. 2021 Annual report of the national poison data system© (NPDS) from America’s Poison Centers: 39th annual report. Clin Toxicol. 2022;60(12):1381–1643. doi: 10.1080/15563650.2022.2132768.
- O’Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. 2007;25(2):333–346. abstract viii. doi: 10.1016/j.emc.2007.02.012.
- Lugassy DM, et al. Salicylates. In: Nelson LS, Howland MA, Lewin NA, editors. Goldfrank’s toxicologic emergencies, 11th ed. New York: McGraw Hill; 2019. p. 555–566.
- Temple AR. Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med. 1981;141(3 Spec No):364–369. doi: 10.1001/archinte.1981.00340030096017.
- American College of Medical Toxicology. Guidance document: management priorities in salicylate toxicity. J Med Toxicol. 2015;11(1):149–152.
- Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine alkalinization. J Toxicol Clin Toxicol. 2004;42(1):1–26. doi: 10.1081/clt-120028740.
- West PL, Horowitz BZ. Delayed recrudescence to toxic salicylate concentrations after salsalate overdose. J Med Toxicol. 2010;6(2):150–154. doi: 10.1007/s13181-010-0070-1.
- Aspirin and other Salicylate Poisoning [published 2020 Aug]. In: Therapeutic guidelines. Melbourne: Therapeutic Guidelines Limited; 2023. https://www.tg.org.au
- Filippone GA, Fish SS, Lacouture PG, et al. Reversible adsorption (desorption) of aspirin from activated charcoal. Arch Intern Med. 1987;147(8):1390–1392. doi: 10.1001/archinte.1987.00370080026006.
- Huynh DA, Abbas M, Dabaja A. Diphenhydramine toxicity. In: StatPearls. Treasure Island, FL: StatPearls Publishing LLC; 2022.